Quince Therapeutics

IPO

Quince

Quince Therapeutics was founded in 2012, is headquartered in South San Francisco, United States, lists 11–50 employees, and has $285.0M in recorded funding across 4 rounds.

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$285.0M
Last Round
$22.0M Corporate RoundJun 2024
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Quince Therapeutics is a late-stage biotechnology company developing treatments for rare diseases. Its AIDE technology platform uses an automated process to encapsulate drugs in a patient's own red blood cells, which the company says may improve tolerability, tissue distribution, immunogenicity, and circulation time. Its lead eDSP program applies this approach to dexamethasone sodium phosphate for patients with ataxia-telangiectasia.

Summary

Quince Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2012. It lists 11–50 employees. It has raised $285.0M in total across 4 rounds, most recently a $22.0M Corporate Round in Jun 2024. Investors include Sequoia Capital, Sofinnova Partners and Pfizer Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Corporate RoundCorporate RoundJun 2024
$22.0M

Sign up to see all 5 events

Funding: Series B through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Quince Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/quince-therapeutics"><img src="https://indexed.vc/api/badge/company/quince-therapeutics" alt="Quince Therapeutics on Indexed.vc" width="260" height="76" /></a>